Discovery of novel TMPRSS2 inhibitors for COVID-19 using in silico fragment-based drug design, molecular docking, molecular dynamics, and quantum mechanics studies
The global expansion of COVID-19 and the mutations of severe acute respiratory syndrome coronavirus necessitate quick development of treatment and vaccination. Because the androgen-responsive serine protease TMPRSS2 is involved in cleaving the SARS-CoV-2 spike protein allowing the virus to enter the...
Үндсэн зохиолчид: | Abdulrahim A. Alzain, PhD, Fatima A. Elbadwi, Fatima O. Alsamani |
---|---|
Формат: | Өгүүллэг |
Хэл сонгох: | English |
Хэвлэсэн: |
Elsevier
2022-01-01
|
Цуврал: | Informatics in Medicine Unlocked |
Нөхцлүүд: | |
Онлайн хандалт: | http://www.sciencedirect.com/science/article/pii/S2352914822000247 |
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Identification of novel TMPRSS2 inhibitors for COVID-19 using e-pharmacophore modelling, molecular docking, molecular dynamics and quantum mechanics studies
-н: Abdulrahim A. Alzain, PhD, зэрэг
Хэвлэсэн: (2021-01-01) -
Identification of novel transmembrane Protease Serine Type 2 drug candidates for COVID-19 using computational studies
-н: Fatima A. Elbadwi, зэрэг
Хэвлэсэн: (2021-01-01) -
Molecular docking between human TMPRSS2 and SARS-CoV-2 spike protein: conformation and intermolecular interactions
-н: Mushtaq Hussain, зэрэг
Хэвлэсэн: (2020-09-01) -
Identification of potent TMPRSS4 inhibitors through structural modeling and molecular dynamics simulations
-н: Ismail Hdoufane, зэрэг
Хэвлэсэн: (2025-01-01) -
Interaction of copper potential metallodrugs with TMPRSS2: A comparative study of docking tools and its implications on COVID-19
-н: Sergio Vazquez-Rodriguez, зэрэг
Хэвлэсэн: (2023-01-01)